IRIS Accounts Production v24.3.0.553 08443219 director 1.4.23 31.3.24 31.3.24 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh084432192023-03-31084432192024-03-31084432192023-04-012024-03-31084432192022-03-31084432192022-04-012023-03-31084432192023-03-3108443219ns15:EnglandWales2023-04-012024-03-3108443219ns14:PoundSterling2023-04-012024-03-3108443219ns10:Director12023-04-012024-03-3108443219ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3108443219ns10:SmallEntities2023-04-012024-03-3108443219ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3108443219ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3108443219ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3108443219ns10:FullAccounts2023-04-012024-03-3108443219ns10:OrdinaryShareClass12023-04-012024-03-3108443219ns10:RegisteredOffice2023-04-012024-03-3108443219ns5:CurrentFinancialInstruments2024-03-3108443219ns5:CurrentFinancialInstruments2023-03-3108443219ns5:ShareCapital2024-03-3108443219ns5:ShareCapital2023-03-3108443219ns5:RetainedEarningsAccumulatedLosses2024-03-3108443219ns5:RetainedEarningsAccumulatedLosses2023-03-310844321912023-04-012024-03-3108443219ns5:FurnitureFittings2023-03-3108443219ns5:FurnitureFittings2023-04-012024-03-3108443219ns5:FurnitureFittings2024-03-3108443219ns5:FurnitureFittings2023-03-3108443219ns10:OrdinaryShareClass12024-03-3108443219ns5:RetainedEarningsAccumulatedLosses2023-03-3108443219ns5:RetainedEarningsAccumulatedLosses2023-04-012024-03-31
REGISTERED NUMBER: 08443219 (England and Wales)













UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

FOR

APOSTOLOS NAKAS THORACIC SURGERY LTD

APOSTOLOS NAKAS THORACIC SURGERY LTD (REGISTERED NUMBER: 08443219)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


APOSTOLOS NAKAS THORACIC SURGERY LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTOR: Dr A Nakas





REGISTERED OFFICE: 12 Nursery Rise
Anstey
Leicester
LE7 7DB





REGISTERED NUMBER: 08443219 (England and Wales)





ACCOUNTANTS: AEH Accountancy Ltd
Church Farm
Main Street
Willey
Warwickshire
CV23 0SH

APOSTOLOS NAKAS THORACIC SURGERY LTD (REGISTERED NUMBER: 08443219)

BALANCE SHEET
31 MARCH 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 2,060 2,061

CURRENT ASSETS
Debtors 6 21,518 18,447
Cash at bank 8,983 9,967
30,501 28,414
CREDITORS
Amounts falling due within one year 7 14,071 11,704
NET CURRENT ASSETS 16,430 16,710
TOTAL ASSETS LESS CURRENT
LIABILITIES

18,490

18,771

CAPITAL AND RESERVES
Called up share capital 8 2 2
Retained earnings 9 18,488 18,769
SHAREHOLDERS' FUNDS 18,490 18,771

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 23 November 2024 and were signed by:





Dr A Nakas - Director


APOSTOLOS NAKAS THORACIC SURGERY LTD (REGISTERED NUMBER: 08443219)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1. STATUTORY INFORMATION

Apostolos Nakas Thoracic Surgery Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the Company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. The estimates and underlying assumptions are based on historical experience and other factors that are considered relevant, Actual results may differ from these estimates.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue comprises the fair value of the consideration received or receivable for the rendering of services in the ordinary course of the company's activities. Revenue is shown net of VAT and trade discounts.

The company recognises revenue when the amount of revenue can be reliably measured, it is probable that future economic benefits will flow to the entity and specific criteria have been met for each of the company's activities. The amount of revenue is not considered to be reliably measurable until all contingencies relating to the sale have been resolved. The company bases its estimates on historical results, taking into consideration the type of customer, the type of transaction and the specifics of each arrangement.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

APOSTOLOS NAKAS THORACIC SURGERY LTD (REGISTERED NUMBER: 08443219)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

3. ACCOUNTING POLICIES - continued

Financial instruments

Financial assets
Receivables are stated at amortised cost using the effective interest rate method. A provision for impairment of receivables is established where there is objective evidence that the company will not be able to collect all amounts due according to the original terms of payment. Receivables are considered for impairment on a case by case basis and any provision is based on the directors' assessment of the amount recoverable on each receivable.

Financial liabilities
The company's financial liabilities include trade and other payables, which are measured at amortised cost using the effective interest rate method. Financial liabilities are recognised when the company becomes a party to the contractual agreements of the instrument. Interest-related charges are recognised as an expense in the period in which they are incurred.

Cash and cash equivalents
Cash and cash equivalents includes cash in hand, deposits held at call with banks, other short-term highly liquid investments with original maturities of three months or less, and bank overdrafts.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - 1 ).

APOSTOLOS NAKAS THORACIC SURGERY LTD (REGISTERED NUMBER: 08443219)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

5. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1 April 2023 13,971
Additions 515
At 31 March 2024 14,486
DEPRECIATION
At 1 April 2023 11,910
Charge for year 516
At 31 March 2024 12,426
NET BOOK VALUE
At 31 March 2024 2,060
At 31 March 2023 2,061

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 21,518 18,447

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors - 1
Tax 149 -
Directors' current accounts 13,232 11,013
Accrued expenses 690 690
14,071 11,704

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
2 Ordinary £1 2 2

9. RESERVES
Retained
earnings
£   

At 1 April 2023 18,769
Profit for the year 719
Dividends (1,000 )
At 31 March 2024 18,488